ARCHIVES

Lilly Made False Claims About Ralozifene Reducing Breast Cancer risk, Judge Rules

This article is from The Cancer Letter archive.

Vol. 25 No. 30 | July 30, 1999

Download PDF Visit The Full Archive

Related Articles

NCI Developing Policy On Relations Between Industry, DCT Clinical Trials

July 29, 1983

ONS Backs Independent Nursing Research, Splits From ASCO On Meetings

September 3, 1982

AACR To Screen Attendees From SARS-Affected Areas.

June 20, 2003

Harkin Withdraws Amendment Allow NIH To Bypass INDS

October 9, 1992

AMA, ACOS, VA Express Interest In Trials; NCI, DCT Board Cool

March 3, 1989

NCI Plans $40M In Grants For Cancer Outcomes Studies.

June 30, 2000